Skip to main content
. 2015 Oct 13;6(40):42667–42686. doi: 10.18632/oncotarget.5626

Figure 3. Akt signalling is required for maintenance of NSCLC LCSs.

Figure 3

A. Immunoblot analysis of Akt phosphorylation status in NCI-H460 and PEd/10 cells treated with MK-2206 and LY294002 at the indicated concentrations. B. Analysis of primary LCSs generated from NCI-H460 and PEd/10 cells treated with MK 2206 and LY294002 at the indicated concentrations. ***p < 0.001, **p < 0.01, *p < 0.05.